A detailed history of Hutner Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hutner Capital Management Inc holds 38,502 shares of ABBV stock, worth $6.85 Million. This represents 3.79% of its overall portfolio holdings.

Number of Shares
38,502
Previous 38,565 0.16%
Holding current value
$6.85 Million
Previous $6.61 Million 14.95%
% of portfolio
3.79%
Previous 3.63%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $10,321 - $12,557
-63 Reduced 0.16%
38,502 $7.6 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $77,395 - $90,380
-500 Reduced 1.28%
38,565 $6.61 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $1,118 - $1,274
7 Added 0.02%
39,065 $7.11 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $114,483 - $128,935
-832 Reduced 2.09%
39,058 $6.05 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $52,634 - $60,932
-394 Reduced 0.98%
39,890 $5.95 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $2,252 - $2,803
17 Added 0.04%
40,284 $5.43 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $12,291 - $14,155
85 Added 0.21%
40,267 $6.42 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $59,888 - $71,821
433 Added 1.09%
40,182 $6.5 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $12,213 - $14,007
91 Added 0.23%
39,749 $5.34 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $11,147 - $14,171
-81 Reduced 0.2%
39,658 $6.07 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $20,852 - $25,872
-158 Reduced 0.4%
39,739 $6.44 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $42,434 - $53,692
-395 Reduced 0.98%
39,897 $5.4 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $19,790 - $22,465
186 Added 0.46%
40,292 $4.35 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $71,227 - $79,351
-677 Reduced 1.66%
40,106 $4.52 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $243,780 - $268,373
2,383 Added 6.21%
40,783 $4.41 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $6,922 - $9,345
86 Added 0.22%
38,400 $4.12 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $366,406 - $430,039
4,265 Added 12.53%
38,314 $3.36 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $679,112 - $908,754
9,256 Added 37.33%
34,049 $3.34 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $16,770 - $25,425
-260 Reduced 1.04%
24,793 $1.89 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $1.65 Million - $2.1 Million
-25,053 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $72,665 - $85,524
-942 Reduced 3.62%
25,053 $2.02 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $56,830 - $70,087
730 Added 2.89%
25,995 $2.4 Million
Q2 2018

Jul 06, 2018

SELL
$89.78 - $106.23 $46,685 - $55,239
-520 Reduced 2.02%
25,265 $2.34 Million
Q1 2018

Apr 06, 2018

SELL
$92.01 - $123.21 $4,600 - $6,160
-50 Reduced 0.19%
25,785 $2.44 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $1.8 Million - $2.3 Million
25,835
25,835 $2.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hutner Capital Management Inc Portfolio

Follow Hutner Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutner Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hutner Capital Management Inc with notifications on news.